Convergence Investment Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,972	Closed	-$220K	–	391
2019 Q1	$220K	Buy	+11,972	New	+$220K	0.05%	261
2018 Q4	–	Sell	-12,489	Closed	-$287K	–	375
2018 Q3	$287K	Buy	+12,489	New	+$287K	0.06%	274